Journal of Biological Chemistry
JBC ReviewsIlluminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapyJBC REVIEWS: Illuminating the Onco-GPCRome
Cited by (0)
This work was supported in part by National Institutes of Health Grants R33CA225291 and U54CA209891 (to S. G. and V. W.) and U01CA196406 (to O. H.) from NCI, U01DE028227 from NIDCR (to S. G. and V. W.), and National Institutes of Health Grants U01-CA217885 and P30-CA023100 (to P. T. and H. Y.), and R01-HG009285, R01-GM074024, R01-CA172513, U24-CA194107, and U24-CA220341 (to P. T.). J. S. G. is a member of the Scientific Advisory Board of Oncoceutics Inc. and Domain Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This article contains Tables S1–S6 and Fig. S1.
- 1
Present address: Oncology Science Unit, MSD K.K., Tokyo 102-8667, Japan.
- 2
Supported by an Alexander Von Humboldt post-doctoral fellowship.
- 3
Supported by the Cell Networks Excellence Initiative of the Germany Research Foundation (DFG) and a Michael J. Fox Foundation Research Grant.
- 4
Supported by JSPS KAKENHI Grant 17K08264, the PRIME JP17gm5910013, and the LEAP JP17gm0010004 from the Japan Agency for Medical Research and Development (AMED).
- 5
Part of the Germany Research Foundation SFB/TPR186 Molecular Switches in the Spatio-Temporal Control of Cellular Signal Transmission and the BMBF German Network for Bioinformatics (de.NBI).